Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy

被引:19
作者
Christensen, Katrine R. [1 ]
Steenholdt, Casper [1 ]
Buhl, Sine S. [1 ]
Ainsworth, Mark A. [1 ]
Thomsen, Ole O. [1 ]
Brynskov, Jorn [1 ]
机构
[1] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark
关键词
TUBERCULOSIS; INFLIXIMAB;
D O I
10.1038/ajg.2015.162
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Implementation of guidelines for prevention of infectious diseases during anti-TNF alpha therapy in patients with inflammatory bowel disease (IBD) is important but difficult. We investigated whether systematic information to health-care professionals about these guidelines improves patients' adherence. METHODS: The study comprised three parts: (1) cross-sectional evaluation of baseline vaccination status in all IBD patients in anti-TNF alpha therapy (reference group; n = 130); (2) prospective interventional study, where health-care professionals received systematic oral and written information about vaccination guidelines at baseline and at 2-month intervals for 6 months, followed by reassessment of vaccination status (intervention group; n = 99); (3) cross-sectional evaluation of representative gastroenterologists' knowledge of guidelines (n = 53). Outcomes were assessed by validated questionnaires. RESULTS: Patients' adherence to vaccination guidelines increased significantly after a period of systematic information to health-care professionals. Hence, complete adherence increased from 5 to 26%, partial adherence from 38 to 56%, and complete non-adherence decreased from 57 to 18% (P < 0.0001). Adherence to all individual vaccinations except human papilloma virus increased significantly (P = 0.0021). Improvement was independent of disease type and anti-TNF alpha agent. At baseline, only 8% of physicians could identify all elements in the reference guideline. Additional barriers reported by physicians were forgetfulness (32%) and insufficient consultation time (26%). Patient-perceived barriers were costs of vaccinations (35%) and forgetfulness (25%). CONCLUSIONS: Gastroenterologists' limited knowledge of vaccination guidelines during anti-TNF alpha therapy can be overcome by systematic education of health-care professionals. This inexpensive and easily accessible intervention immediately results in markedly improved patient adherence. Remaining obstacles for adherence comprise high vaccination costs and forgetfulness.
引用
收藏
页码:1526 / 1532
页数:7
相关论文
共 16 条
[1]   Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis [J].
Esteve, M ;
Saro, C ;
González-Huix, F ;
Suarez, F ;
Forné, M ;
Viver, JM .
GUT, 2004, 53 (09) :1363-1365
[2]   Documented Compliance with Inflammatory Bowel Disease Quality Measures Is Poor [J].
Feuerstein, Joseph D. ;
Lewandowski, Jeffrey J. ;
Martinez-Vazquez, Manuel ;
Leffler, Daniel A. ;
Cheifetz, Adam S. .
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) :339-344
[3]  
Huth KBE, 2014, UNITED EUROPEAN GAST, V2, pA228
[4]   Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].
Keane, J ;
Gershon, S ;
Wise, RP ;
Mirabile-Levens, E ;
Kasznica, J ;
Schwieterman, WD ;
Siegel, JN ;
Braun, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104
[5]   Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses [J].
Melmed, Gil Y. ;
Ippoliti, Andrew F. ;
Papadakis, Konstantinos A. ;
Tran, Tram T. ;
Birt, Jaime L. ;
Lee, Susie K. ;
Frenck, Robert W. ;
Targan, Stephan R. ;
Vasiliauskas, Eric A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08) :1834-1840
[6]   Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease [J].
Nielsen, Ole Haagen ;
Ainsworth, Mark Andrew .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :754-762
[7]   A Quality Improvement Project Significantly Increased the Vaccination Rate for Immunosuppressed Patients with IBD [J].
Parker, Siddhartha ;
White, Laura Chambers ;
Spangler, Chad ;
Rosenblum, Jessica ;
Sweeney, Shannon ;
Homan, Emily ;
Bensen, Steven P. ;
Levy, L. Campbell ;
Dragnev, Maria Conception C. ;
Moskalenko-Locke, Kristen ;
Rich, Pamela ;
Siegel, Corey A. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) :1809-1814
[8]   Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease [J].
Rahier, J. F. ;
Magro, F. ;
Abreu, C. ;
Armuzzi, A. ;
Ben-Horin, S. ;
Chowers, Y. ;
Cottone, M. ;
de Ridder, L. ;
Doherty, G. ;
Ehehalt, R. ;
Esteve, M. ;
Katsanos, K. ;
Lees, C. W. ;
MacMahon, E. ;
Moreels, T. ;
Reinisch, W. ;
Tilg, H. ;
Tremblay, L. ;
Veereman-Wauters, G. ;
Viget, N. ;
Yazdanpanah, Y. ;
Eliakim, R. ;
Colombel, J. F. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (06) :443-468
[9]   European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease [J].
Rahier, J. F. ;
Ben-Horin, S. ;
Chowers, Y. ;
Conlon, C. ;
De Munter, P. ;
D'Haens, G. ;
Domenech, E. ;
Eliakim, R. ;
Eser, A. ;
Frater, J. ;
Gassull, M. ;
Giladi, M. ;
Kaser, A. ;
Lemann, M. ;
Moreels, T. ;
Moschen, A. ;
Pollok, R. ;
Reinisch, W. ;
Schunter, M. ;
Stange, E. F. ;
Tilg, H. ;
Van Assche, G. ;
Viget, N. ;
Vucelic, B. ;
Walsh, A. ;
Weiss, G. ;
Yazdanpanah, Y. ;
Zabana, Y. ;
Travis, S. P. L. ;
Colombel, J. F. .
JOURNAL OF CROHNS & COLITIS, 2009, 3 (02) :47-91
[10]   Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease [J].
Siegel, Corey A. ;
Allen, John I. ;
Melmed, Gil Y. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) :908-912